151 related articles for article (PubMed ID: 10448603)
41. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
[TBL] [Abstract][Full Text] [Related]
42. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
43. [Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes].
Scudla V; Jarosová M; Kapustová M; Indrák K
Vnitr Lek; 1990 Nov; 36(11):1081-91. PubMed ID: 2267738
[TBL] [Abstract][Full Text] [Related]
44. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma.
Meeus P; Stul MS; Mecucci C; Cassiman JJ; Van den Berghe H
Cancer Genet Cytogenet; 1995 Aug; 83(1):25-7. PubMed ID: 7656199
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.
Yokoi S; Sakai H; Uchida A; Uemura Y; Sato K; Tsuruoka Y; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Inoue Y; Hoshikawa M; Miura I
J Clin Exp Hematop; 2015; 55(3):137-43. PubMed ID: 26763361
[TBL] [Abstract][Full Text] [Related]
46. Burkitt's type translocation in multiple myeloma.
Solé F; Woessner S; Acín P; Pérez-Losada A; Florensa L; Besses C; Sans-Sabrafen J
Leuk Res; 1994 Sep; 18(9):671-3. PubMed ID: 7934142
[TBL] [Abstract][Full Text] [Related]
47. Cytogenetic abnormalities in a hemangiopericytoma of the spleen.
Hallén M; Parada LA; Gorunova L; Pålsson B; Dictor M; Johansson B
Cancer Genet Cytogenet; 2002 Jul; 136(1):62-5. PubMed ID: 12165454
[TBL] [Abstract][Full Text] [Related]
48. Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma.
Fiedler W; Weh HJ; Hossfeld DK
Br J Haematol; 1992 May; 81(1):58-61. PubMed ID: 1520625
[TBL] [Abstract][Full Text] [Related]
49. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
[TBL] [Abstract][Full Text] [Related]
50. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.
Dewald GW; Kyle RA; Hicks GA; Greipp PR
Blood; 1985 Aug; 66(2):380-90. PubMed ID: 3926026
[TBL] [Abstract][Full Text] [Related]
51. New complex chromosome abnormalities in multiple myeloma associated with a poor prognosis: a case report.
Fett-Conte AC; Carvalho-Salles AB; Vendrame CB; Pedrassa P; Freitas PC; Varella-Garcia M
Leuk Res; 2012 Jul; 36(7):e140-2. PubMed ID: 22502921
[No Abstract] [Full Text] [Related]
52. Molecular aspects of multiple myeloma.
Pratt G
Mol Pathol; 2002 Oct; 55(5):273-83. PubMed ID: 12354927
[TBL] [Abstract][Full Text] [Related]
53. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
54. [Analysis of clinical features of multiple myeloma with t(8;14)(q24;q32)].
He Q; Duan WB; Wen L; Liu Y; Ma L; Wang FR; Huang XJ; Lu J
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(30):2363-2367. PubMed ID: 35970795
[No Abstract] [Full Text] [Related]
55. Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma.
Ross FM; Ibrahim AH; Vilain-Holmes A; Winfield MO; Chiecchio L; Protheroe RK; Strike P; Gunasekera JL; Jones A; Harrison CJ; Morgan GJ; Cross NC;
Leukemia; 2005 Sep; 19(9):1634-42. PubMed ID: 15990862
[TBL] [Abstract][Full Text] [Related]
56. Incidence and prognostic value of recurrent chromosomal abnormalities in elderly patients with multiple myeloma.
Braggio E
Future Oncol; 2013 Dec; 9(12):1805-8. PubMed ID: 24295409
[TBL] [Abstract][Full Text] [Related]
57. Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
Smetana J; Berankova K; Zaoralova R; Nemec P; Greslikova H; Kupska R; Mikulasova A; Frohlich J; Sevcikova S; Zahradova L; Krejci M; Sandecka V; Almasi M; Kaisarova P; Melicharova H; Adam Z; Penka M; Jarkovsky J; Jurczyszyn A; Hajek R; Kuglik P
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):123-30. PubMed ID: 23291040
[TBL] [Abstract][Full Text] [Related]
58. [Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients].
Jarosová M; Scudla V; Indrák K; Kapustová M
Vnitr Lek; 1990 Nov; 36(11):1072-80. PubMed ID: 2267737
[TBL] [Abstract][Full Text] [Related]
59. Two cases of t(9;20) in multiple myeloma.
Jarosová M; Scudla V; Bacovský ; Indrák K; Sousková I; Bĕhal K
Cancer Genet Cytogenet; 1996 Sep; 90(2):106-8. PubMed ID: 8830717
[TBL] [Abstract][Full Text] [Related]
60. Multiple apparently unrelated clonal chromosome abnormalities in a squamous cell carcinoma of the tongue.
Jin YS; Heim S; Mandahl N; Biörklund A; Wennerberg J; Mitelman F
Cancer Genet Cytogenet; 1988 May; 32(1):93-100. PubMed ID: 3162710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
